Diagnio

Founded 2022
Employees 5+
Primary contact
IN5 Tech, Dubai Internet City
1sy Floor, HD22C
Dubai
United Arab Emirates

Diagnio is a FemTech startup with a mission to transform hormonal diagnostics and help women get a clear understanding of their reproductive health through an accessible, accurate, and comfortable at-home test system. The company's first product, Diagnio Ovulation Test Kit, uses a saliva sample to measure estrogen levels and determine the cycle phase and ovulation via mobile application. It is an FDA Class 1-cleared device.

💸
This company is raising funds!
Click here to download its pitchdeck
Founded 2022
Employees 5+
Primary contact
IN5 Tech, Dubai Internet City
1sy Floor, HD22C
Dubai
United Arab Emirates

Funding 💰

Total $380K
Select investors Alchemist Accelerator, Expert DOJO, in5, NRG Ventures, Flat6Labs

Key people 🧑‍🤝‍🧑

Highlights

  • Fertility tracking: Diagnio's device lets women accurately determine whether and when ovulation occurs. As such, it could be used to plan the desired pregnancy or monitor safe days to ensure the contraception strategy.
  • Cycle movement tracking: Diagnio's mobile app has a calendar to mark menstruations, pain levels, and intimacy, together with measured estrogen levels. This lets women fully know their cycle movements and confirm it with Diagnio's smart test. The app also features a personalized diary with a complete history of events during previous cycles and an intelligent prediction of the next.
  • Well-being tracking: The app also features health & well-being questionnaires to determine the user's stress levels, pain patterns, etc. at different cycle phases and determine how they correlate with the hormone levels. Diagnio provides a personal well-being score according to the user's desired goal.

Video ▶️

In the news 📰

Last update: November 10, 2024